timolol has been researched along with Cancer of Eye in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, Y; Lei, S; Li, J; Long, J; Shi, Q; Wu, Q | 1 |
Elmazar, HF; Khairy, HA; Mandour, SS; Marey, HM | 1 |
Adams, BH; Broderick, DF; Menke, DM; Runyan, BR; Shetty, RK; Tun, HW | 1 |
Dombi, TM; Huang, K; Jessen, B; Kwok, KK; Tressler, CS; Wirostko, BM; Wiseman, RL | 1 |
1 review(s) available for timolol and Cancer of Eye
Article | Year |
---|---|
Lack of evidence for a link between latanoprost use and malignant melanoma: an analysis of safety databases and a review of the literature.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Child; Child, Preschool; Databases, Factual; Drug Combinations; Evidence-Based Medicine; Eye Neoplasms; Female; Humans; Latanoprost; Male; Melanoma; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prostaglandins F, Synthetic; Skin Neoplasms; Timolol; Young Adult | 2011 |
1 trial(s) available for timolol and Cancer of Eye
Article | Year |
---|---|
Combined Oral and Topical Beta Blockers for the Treatment of Early Proliferative Superficial Periocular Infantile Capillary Hemangioma.
Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Drug Therapy, Combination; Eye Neoplasms; Female; Follow-Up Studies; Hemangioma, Capillary; Humans; Infant; Male; Neoplasm Staging; Neoplastic Syndromes, Hereditary; Ophthalmic Solutions; Propranolol; Retrospective Studies; Time Factors; Timolol; Treatment Outcome | 2018 |
2 other study(ies) available for timolol and Cancer of Eye
Article | Year |
---|---|
[Usage and efficacy of timolol maleate eye drops in treatment of superficial infantile hemangioma].
Topics: Administration, Topical; Drug Administration Schedule; Eye Neoplasms; Hemangioma; Humans; Infant; Ophthalmic Solutions; Timolol; Treatment Outcome | 2017 |
Use of rituximab for periocular and intraocular mucosa-associated lymphoid tissue lymphoma.
Topics: Androstadienes; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Brimonidine Tartrate; Drug Therapy, Combination; Eye Neoplasms; Female; Glaucoma; Humans; Latanoprost; Loteprednol Etabonate; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Parotid Neoplasms; Prostaglandins F, Synthetic; Quinoxalines; Rituximab; Sulfonamides; Thiophenes; Timolol | 2010 |